Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation

Blood

Volumn 116, Issue 1, 2010, Pages 27-35

  Bordon, Victoria ^a   Gennery, Andrew R ^b   Slatter, Mary A ^b   Vandecruys, Els ^a   Laureys, Genevieve ^a   Veys, Paul ^c   Waseem, Qasim ^c   Friedrich, Wilhelm ^d   Wulfraat, Nico M ^e   Scherer, Franziska ^f   Cant, Andrew J ^b   Fischer, Alain ^g   Cavazanna Calvo, Marina ^g   Bredius, Robbert G M ^h   Notarangelo, Luigi D ⁱ   Mazzolari, Evelina ^j   Neven, Benedicte ^g   Tayfun, Güngör ^f  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ BOSTON CHILDREN S HOSPITAL   (United States)

^j SPEDALI CIVILI   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MELPHALAN; METHOTREXATE; OKT 3; RITUXIMAB; THIOTEPA; TREOSULFAN; RNA COMPONENT OF MITOCHONDRIAL RNA PROCESSING ENDORIBONUCLEASE, HUMAN; UNTRANSLATED RNA;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; AUTOSOMAL RECESSIVE DISORDER; B LYMPHOCYTE; CARTILAGE HAIR HYPOPLASIA; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMBINED IMMUNODEFICIENCY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DYSREGULATION; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; LYMPHOCYTE COUNT; LYMPHOMA; MALE; MYELOABLATIVE CONDITIONING; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; T LYMPHOCYTE; BLOOD; BODY HEIGHT; BODY WEIGHT; BONE DYSPLASIA; CARTILAGE; CONGENITAL MALFORMATION; CYTOLOGY; GENETICS; HYPOTRICHOSIS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE SUBPOPULATION; METHODOLOGY; MUTATION; OUTCOME ASSESSMENT; PRESCHOOL CHILD;

ADOLESCENT; BODY HEIGHT; BODY WEIGHT; BONE DISEASES, DEVELOPMENTAL; CARTILAGE; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOTRICHOSIS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MALE; MUTATION; OUTCOME ASSESSMENT (HEALTH CARE); RNA, UNTRANSLATED;

EID: 77955937235     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-01-259168     Document Type: Article

References (46)

1. McKusick V, Eldrige R, Hostetler J, Ruangwit U, Egeland J. Dwarfism in the Amish. II. Cartilage hair hypoplasia. Bull John Hopkins Hosp. 1965;116:285-326.
2. Makitie O. Cartilage-hair hypoplasia in Finland: epidemiological and genetic aspects of 107 patients. J Med Genet. 1992;29(9):652-655.
3. Makitie O, Juvonen E, Dunkel L, Kaitila I, Siimes M. Anemia in children with cartilage-hair hypoplasia is related to body growth and to the insulin-like growth factor system. J Clin Endocrinol Metab. 2000;85(2):563-568. (Pubitemid 32273635)
4. Makitie O, Pukkala E, Teppo L, Kaitila I. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J Pediatr. 1999;134(3):315-318. (Pubitemid 30417640)
5. Spranger J, Brill P, Poznanski A. Bone Dysplasias: An Atlas of Genetic Disorders of Skeletal Development. 2nd edition. Oxford: Oxford University Press; 2003.
6. Maida Y, Yasukawa M, Furuuchi M, et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature. 2009;461(7261):230-235.
7. Bonafé L, Schmitt K, Eich G, Giedion A, Superti-Furga A. RMRP gene sequence analysis confirms a cartilage-hair hypoplasia variant with only skeletal manifestations and reveals a high density of single-nucleotide polymorphism. Clin Genet. 2002;61(2):146-151. (Pubitemid 36372620)
8. Sulisalo T, Sistonen P, Hastbacka J, et al. Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis. Nat Genet. 1993;3(4):338-341. (Pubitemid 23112960)
9. Ridanpaa M, van Eenennaam H, Pelin K, et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell. 2001;104(2):195-203. (Pubitemid 32174836)
10. Bonafé L, Dermitzakis E, Unger S, et al. Evolutionary comparison provides evidence for pathogenicity of RMRP mutations. PLoS Genet. 2005;1(4):444-454.
11. Ridanpaa M, Sulisalo T, de la Chapelle A, Kaitila I. Genetic and physical mapping of the cartilage-hair hypoplasia locus on 9p13 (abstract). Am J Hum Genet. 1995;57(suppl):A201.
12. Hermanns P, Bertuch A, Bertin T, et al. Consequences of mutations in the non-coding RMRP RNA in cartilage-hair hypoplasia. Hum Mol Genet. 2005;14(23):3723-3740. (Pubitemid 41754671)
13. Clayton D. A big development for a small RNA. Nature. 2001;410(6824):29-31.
14. Thiel C, Horn D, Zabel B, et al. Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator. Am J Hum Genet. 2005;77(5):795-806. (Pubitemid 41513281)
15. Makitie O, Kaitila I, Savilahti E. Susceptibility to infections and in vitro immune functions in cartilage-hair hypoplasia. Eur J Pediatr. 1998;157(10):816-820. (Pubitemid 28460742)
16. Maikitie O, Kaitila I, Savilahti. Deficiency of humoral immunity in cartilage-hair hypoplasia. Eur J Pediatr. 2000;137(4):487-492.
17. Mäkitie O, Kaitila I. Cartilage-hair hypoplasia: clinical manifestations in 108 Finnish patients. Eur J Pediatr. 1993;152(3):211-217. (Pubitemid 23053247)
18. Taskinen M, Ranki A, Pukkala E, Jeskanen L, Kaitila I, Mäkitie O. Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am J Med Genet A. 2008;146A(18):2370-2375.
19. Mäkitie O, Pukkala E, Kaitila I. Increased mortality in Cartilage-hair hypoplasia. Arch. Dis. Child. 2001;84(1):65-67.
20. Borisch B, Raphael M, Swerdlow SH, Jaffe ES. Lymphoproliferative diseases associated with primary immune disorders. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organisation Classification of Tumours: Tumours of the Haematopoietic and Lymphoid Tissues, 2001. International Ag for Research on Cancer, Lyon, France; IARC Press, 257-259.
21. Pinkerton CR, Hann I, Weston CL, et al. Immunodeficiency- related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry. Br J Haematol. 2002;118(2):456-461. (Pubitemid 34994649)
22. Kavadas F, Gilliani S, Gu Y, et al. Variability of clinical and laboratory features among patients with ribonuclease mithocondrial RNA processing endoribonuclease gene mutations. J Allergy Clin Immunol. 2008;122(6):1178-1184.
23. Berthet F, Le Deist F, Duliege AM, Griscelli C, Fischer A. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency). Pediatrics. 1994;93(2):265-270. (Pubitemid 24047164)
24. Antoine C, Müller S, Cant A, et al. Long-term survival and transplantation of haematopoietic stem cells for immunodeficiencies: report of the European experience, 1968-99. Lancet. 2003;361(9357):553-560.
25. Gennery AR, Khawaja K, Veys P, et al. for the European Group for Blood and Bone Marrow Transplantation and the European Society for Immunodeficiency. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993-2002. Blood. 2004;103(3):1152-1157.
26. Winkelstein JA, Marino MC, Johnston RB, et al. Chronic granulomatous disease: report on a national registry of 368 patients. Medicine. 2000;79(3):155-169. (Pubitemid 30327530)
27. Seger RA, Gungor T, Belohradsky BH, et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood. 2002;100(13):4344-4350.
28. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97(6):1598-1603.
29. Purtilo DT, Grierson HL. Methods of detection of new families with X-linked lymphoproliferative disease. Cancer Genet Cytogenet. 1991;51(2):143-153.
30. Rigaud S, Fondaneche MC, Lambert N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006;444(7115):110-114. (Pubitemid 44684766)
31. Lancaster AC, Visser LF, Hartwig NG, et al. Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. Blood. 2005;36(2):99-105.
32. Ehrlich M, Jackson K, Weemaes C. Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis. 2006;1(2):1-9.
33. Gennery AR, Slatter MA, Bhattacharya A, et al. Bone marrow transplantation for Nijmegen breakage syndrome. J Pediatr Hematol Oncol. 2005;27(4):239. (Pubitemid 40604852)
34. Gungor T, Corbacioglu S, Storb R, Seger RA. Non-myeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita. Bone Marrow Transplant. 2003;31(3):407-410. (Pubitemid 36410689)
35. Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003;111(5):622-627.
36. Berthet F, Siegrist C, Ozsahin H, et al. Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia. Eur J Pediatr. 1996;155(4):286-290. (Pubitemid 26096393)
37. Kuijpers TW, Rindapää M, Peters M, et al. Short-limbed dwarfism with bowing, combined immune deficiency, and late onset aplastic anaemia caused by novel mutations in the RMPR gene. J Med Genet. 2003;40(10):761-766. (Pubitemid 37311076)
38. Guggenheim R, Somech R, Grunebaum E, Atkinson A, Roifman C. Bone marrow transplantation for cartilage-hair-hypoplasia. Bone Marrow Transplant. 2006;38(11):751-756.
39. Makitie O, Perheentupa J, Kaitila I. Growth in cartilage-hair hypoplasia. Pediatr Res. 1992;31(2):176-180.
40. Pierce GF, Polmar SH. Lymphocyte dysfunction in cartilage hair hypoplasia: evidence for a cell cycle specific defect in T cell growth. Clin Exp Immunol. 1982;50(3):621-628.
41. Pierce GF, Polmar SH. Lymphocyte dysfunction in cartilage hair hypoplasia: evidence for an intrinsic defect in cellular proliferation. Clin Exp Immunol. 1982;129(2):570-575. (Pubitemid 12039377)
42. Kooijman R, Van der Burgt CJAM, Weesmaes CMR, Haraldsson A, Scholtens Zegers BJM. T cell subsets and T cell function in cartilage-hair hypoplasia. Scand J Immunol. 1997;46(2):209-215. (Pubitemid 27323850)
43. Poliani PL, Facchetti F, Ravanini M, et al. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood. 2009;114(1):105-108.
44. McLean-Tooke A, Spickett GP, Gennery AR. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol. 2007;66(1):1-7. (Pubitemid 46985514)
45. Notarangelo LD, Roifman CH, Giliani S. Cartilage-hair hypoplasia: molecular and heterogeneity of the immunological phenotype. Curr Opin Allergy Clin Immunol. 2008;8(6):534-539.
46. Ashby G, Evans D. Cartilage hair hypoplasia with thrombocytopenic purpura, autoimmune haemolytic anaemia and cell-mediated immunodeficiency. J R Soc Med. 1986;79(2):113-114. (Pubitemid 16123795)